Journal Article Summary
The article investigates the use of oseltamivir, an antiviral medication, in children hospitalized with community-acquired, laboratory-confirmed influenza. This topic is significant because timely treatment with oseltamivir can reduce the severity and duration of influenza symptoms if administered within 48 hours of symptom onset. Despite its potential benefits, there is limited research on how often this medication is prescribed to hospitalized children, which is crucial for improving treatment outcomes in this vulnerable population.
The study analyzed data from 929 children aged 21 years or younger who were hospitalized with influenza over five seasons from 2000 to 2005. It found that only 32.8% of these patients were eligible for oseltamivir treatment based on FDA guidelines, but only 16.1% of those eligible actually received the medication during their hospital stay. While the rate of on-label prescriptions increased significantly over the study period, the implementation of an electronic reminder system to encourage appropriate prescribing did not lead to a notable change in prescription rates.
The study has several limitations, including its retrospective design, which may introduce biases in how data was collected and interpreted. Additionally, the electronic reminder did not significantly impact prescription practices, suggesting that further improvements are needed in how healthcare providers are supported in making treatment decisions. Patients and caregivers should discuss the importance of timely antiviral treatment for influenza with their healthcare professionals, especially if symptoms arise, to ensure appropriate care and management of the illness.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Wilkes Jennifer J., Zaoutis Theoklis E., Keren Ron, Desai Bimal, Leckerman Kateri H., Hodinka Richard L., Metjian Talene A., Coffin Susan E.. Treatment with Oseltamivir in Children Hospitalized with Community-Acquired, Laboratory-Confirmed Influenza: Review of Five Seasons and Evaluation of an Electronic Reminder. Journal of hospital medicine 2009. DOI: 10.1002/jhm.431. PMID: 19301375. PMCID: PMC13213538.
Featured Pill Pals Product
Oseltamivir Phosphate 6 mg / ml Oral Suspension --- Generic For Tamiflu (60 ml Total) --- Ajanta Pharma
Oseltamivir Phosphate 6 mg / ml Oral Suspension --- Generic For Tamiflu (60 ml Total) --- Ajanta Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
